Stocks and Investing
by (remove) : Paul Choi
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Paul Choi
RSSJSONXMLCSV
Tue, September 17, 2024
Tue, August 13, 2024
Thu, February 1, 2024
Mon, July 31, 2023
Fri, July 21, 2023
Thu, July 20, 2023
Tue, July 18, 2023
Tue, March 7, 2023
Thu, February 23, 2023
Tue, February 21, 2023
Wed, December 14, 2022
Thu, October 20, 2022
Tue, May 24, 2022
Tue, March 22, 2022
Thu, December 23, 2021
Wed, October 6, 2021
Wed, September 22, 2021
Wed, May 12, 2021
Fri, May 7, 2021
Mon, March 22, 2021
Tue, February 9, 2021
Mon, September 14, 2020
Tue, March 31, 2020
Fri, March 13, 2020
Tue, February 4, 2020
Tue, November 5, 2019
Tue, October 15, 2019

Paul Choi Maintained (ASND) at Strong Buy with Increased Target to $200 on, Sep 17th, 2024


Published on 2024-10-28 14:18:46 - WOPRAI, Paul Choi
  Print publication without navigation


Paul Choi of Goldman Sachs, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $180 to $200 on, Sep 17th, 2024.

Paul has made no other calls on ASND in the last 4 months.



There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 0 agree with Paul's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Paul


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $170 on, Monday, September 16th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $175 on, Wednesday, September 4th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Strong Buy with Decreased Target to $157 on, Wednesday, September 4th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $165 on, Wednesday, September 4th, 2024
  • Kelly Shi of "Jefferies" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, August 13th, 2024
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $200 on, Friday, May 31st, 2024
Contributing Sources